Weld Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Weld Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,333	Closed	-$610K	–	640
2020 Q4	$610K	Sell	8,333 -5,160	-38%	-$384K	0.24%	143
2020 Q3	$1.05M	Buy	+13,493	New	+$928K	0.41%	62
2019 Q3	–	Sell	-14,015	Closed	-$337K	–	1110
2019 Q2	$337K	Sell	14,015 -53,261	-79%	-$1.35M	0.06%	510
2019 Q1	$1.78M	Buy	67,276 +9,757	+17%	+$231K	0.32%	68
2018 Q4	$1.12M	Buy	+57,519	New	+$1.13M	0.25%	106

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Weld Capital Management's HZNP Position: Q1 2021 in Review

Weld Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 8,333 shares — an estimated $610K sold.

Weld Capital Management first reported a position in HZNP in Q4 2018 and held it in 5 quarters. The position peaked at $1.78M in Q1 2019. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

Weld Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Weld Capital Management sold 8,333 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $610K.
Weld Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 5 quarters.
Weld Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.78M in Q1 2019.
516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.